About Dallas Formulations Private Limited
Data last updated: 18 December 2025
Dallas Formulations Private Limited is a private limited company based in Ujjain, Madhya Pradesh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 24 November 2000, the company has been in operation for over 26 years.
Registered with ROC Gwalior under CIN U24233MP2000PTC014476.
Capital: an authorised share capital of ₹50 Lakh and a paid-up capital of ₹39.09 Lakh. Formerly known as Chirayu Ayurveda Private Limited. It is led by directors Rajesh Gupta and Mukesh Kumar.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: 220 Block – C 2Nd Floor Madhav Club Road Dawa Bazar, Ujjain, Madhya Pradesh, India – 456010.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.53 Cr, a growth of 47% compared to the previous year.
The company has a workforce of approximately 22 employees as per the latest available data.
The company is associated with 1 brand - Dallas Formulations. As per MCA filings, the company has open charges of ₹2.66 Cr and satisfied charges of ₹5.24 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dallaspharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address220 Block – C 2Nd Floor Madhav Club Road Dawa Bazar, Ujjain, Madhya Pradesh, India – 456010
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Dallas Formulations Private Limited
Dallas Formulations Private Limited operates one associated brand: Dallas Formulations. These brands represent Dallas Formulations Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical tablets, capsules, and injectables for health markets. | dallaspharma.com |
Competitors & Alternatives of Dallas Formulations Private Limited
Brands and companies operating in the same space as Dallas Formulations Private Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India, India | 1978 |
|
|
CDMO focusing on spectrum of dosage forms and therapeutic segments | Delhi, India, India | 2004 |
|
|
Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India, India | 1995 |
|
|
Biopharma regulatory affairs, quality control, and strategy services are provided. | Gurugram, India, India | 2001 |
|
|
Contract development and manufacturing organization for proprietary and generic drugs | Paris, France, France | 1993 |
|
|
Pharmaceutical development and manufacturing services are offered contractually. | Jordbro, Sweden, Sweden | 1995 |
|
|
CDMO with a focus on early phase drug product development | Clearwater, United States, United States | 2006 |
|
|
Topical and inhaled drug delivery formulations are developed and manufactured. | Guildford, United Kingdom, United Kingdom | 1998 |
Business Activity of Dallas Formulations Private Limited
Dallas Formulations Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Dallas Formulations Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Dallas Formulations Private Limited
Dallas Formulations Private Limited is audited by V.K. Ladha & Associates for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V.K. Ladha & Associates | Locked | Locked | Locked |
Complete auditor history for Dallas Formulations Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dallas Formulations Private Limited
Dallas Formulations Private Limited is currently managed by 2 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Rajesh Gupta
Also directs:
Rudraksha Entertainment Llp, Dallas Drugs Private Limited, Dauket Pharma Private Limited and 2 more
|
Director | 16 Jan 2006 | 20 Years 7 Months | Current |
| Mukesh Kumar | Whole-Time Director | 21 Jul 2022 | 4 Years 0 Months | Current |
Financials of Dallas Formulations Private Limited FY 2024 filings available
Dallas Formulations Private Limited reported revenue of ₹10.53 Cr (up 47.00% YoY) for FY 2025.
Ten-year financial statements for Dallas Formulations Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Dallas Formulations Private Limited
Shareholding and ownership data for Dallas Formulations Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dallas Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Nov 2006 | State Bank of India | ₹2.66 Cr | Open |
| 28 Nov 2013 | Ing Vysya Bank Limited | ₹1.75 Cr | Satisfied |
| 17 Aug 2011 | Dir. of Industries with Parri Passu Sbi Baddi | ₹1.29 Cr | Satisfied |
| 29 Apr 2006 | State Bank of India | ₹2.2 Cr | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Dallas Formulations Private Limited
Dallas Formulations Private Limited has a workforce of 22 employees as of Mar 24, 2025.
Employee and EPFO history for Dallas Formulations Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Dallas Formulations Private Limited
GST registrations and filing compliance for Dallas Formulations Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Dallas Formulations Private Limited
Credit ratings, litigation, and regulatory alerts for Dallas Formulations Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dallas Formulations Private Limited
MSME payment history for Dallas Formulations Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dallas Formulations Private Limited
Corporate group structure for Dallas Formulations Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dallas Formulations Private Limited
MCA filings and documents for Dallas Formulations Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Dallas Formulations Private Limited
Frequently Asked Questions about Dallas Formulations Private Limited
Dallas Formulations Private Limited is an active private limited company in the pharma sector based in Ujjain, Madhya Pradesh, India. It was incorporated on 24 November 2000 (26+ years old) and is registered under CIN U24233MP2000PTC014476. The company has 22 employees.
Dallas Formulations Private Limited reported revenue of ₹10.53 Cr for FY 2025 (up 47.00% YoY).
The current directors of Dallas Formulations Private Limited are:
- Rajesh Gupta - Director
- Mukesh Kumar - Whole-Time Director
The primary industry of Dallas Formulations Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Dallas Formulations Private Limited can be reached at the registered office: 220 Block – C 2Nd Floor Madhav Club Road Dawa Bazar, Ujjain, Madhya Pradesh, India – 456010, or through the website dallaspharma.com.
The authorised capital is ₹50 Lakh, and the paid-up capital is ₹39.09 Lakh.